Vanguard Group Inc. Boosts Stock Holdings in Phreesia, Inc. $PHR

Vanguard Group Inc. raised its position in shares of Phreesia, Inc. (NYSE:PHR) by 8.3% in the third quarter, Holdings Channel.com reports. The fund owned 5,704,786 shares of the company’s stock after acquiring an additional 437,462 shares during the quarter. Vanguard Group Inc. owned approximately 0.10% of Phreesia worth $134,177,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Raymond James Financial Inc. raised its stake in Phreesia by 2.7% in the 2nd quarter. Raymond James Financial Inc. now owns 14,049 shares of the company’s stock valued at $400,000 after purchasing an additional 375 shares during the last quarter. PNC Financial Services Group Inc. grew its holdings in shares of Phreesia by 2.8% during the second quarter. PNC Financial Services Group Inc. now owns 19,983 shares of the company’s stock worth $569,000 after buying an additional 540 shares in the last quarter. Diversified Trust Co raised its position in shares of Phreesia by 1.7% in the third quarter. Diversified Trust Co now owns 45,822 shares of the company’s stock valued at $1,078,000 after buying an additional 780 shares during the last quarter. Bank of Montreal Can lifted its stake in shares of Phreesia by 9.2% in the second quarter. Bank of Montreal Can now owns 11,277 shares of the company’s stock worth $321,000 after buying an additional 950 shares in the last quarter. Finally, Police & Firemen s Retirement System of New Jersey grew its stake in Phreesia by 8.8% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 12,847 shares of the company’s stock valued at $366,000 after acquiring an additional 1,034 shares in the last quarter. 92.10% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently issued reports on PHR. Truist Financial set a $24.00 price target on Phreesia in a research report on Thursday, January 8th. Barclays dropped their target price on Phreesia from $26.00 to $24.00 and set an “overweight” rating for the company in a report on Tuesday, December 16th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Phreesia in a report on Wednesday, January 28th. Citigroup dropped their price objective on shares of Phreesia from $29.00 to $25.00 and set a “buy” rating for the company in a report on Friday, January 9th. Finally, Wells Fargo & Company began coverage on shares of Phreesia in a research note on Thursday, January 8th. They set an “overweight” rating and a $30.00 target price on the stock. Seventeen analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $29.12.

Phreesia Stock Up 1.1%

Shares of NYSE:PHR opened at $12.40 on Wednesday. The firm has a market capitalization of $747.60 million, a PE ratio of -123.99 and a beta of 0.67. Phreesia, Inc. has a 1 year low of $11.31 and a 1 year high of $32.76. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.44 and a quick ratio of 2.44. The firm’s 50-day moving average is $14.52 and its two-hundred day moving average is $20.07.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Monday, December 8th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.11. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The business had revenue of $120.33 million during the quarter, compared to analyst estimates of $119.98 million. During the same quarter last year, the firm posted ($0.25) earnings per share. The business’s revenue for the quarter was up 12.7% compared to the same quarter last year. Analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.

Insider Buying and Selling at Phreesia

In other Phreesia news, CFO Balaji Gandhi sold 4,687 shares of Phreesia stock in a transaction dated Friday, January 16th. The stock was sold at an average price of $16.36, for a total transaction of $76,679.32. Following the completion of the sale, the chief financial officer directly owned 150,569 shares of the company’s stock, valued at $2,463,308.84. The trade was a 3.02% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, General Counsel Allison C. Hoffman sold 3,995 shares of the stock in a transaction dated Friday, January 16th. The shares were sold at an average price of $16.36, for a total value of $65,358.20. Following the completion of the transaction, the general counsel owned 169,661 shares in the company, valued at approximately $2,775,653.96. The trade was a 2.30% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 60,766 shares of company stock worth $1,013,817. 5.50% of the stock is currently owned by company insiders.

Phreesia Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.